Judith C. van Deutekom

2.3k citations

15 papers · 1.8k indexed · 2 hit papers · h-index 12

Molecular Biology top 5%
Genetics top 2%
Genetics top 5%
Cardiology and Cardiovascular Medicine top 5%
Physiology top 10%

Co-authors: Annemieke Aartsma‐Rus Anneke A. M. Janson Sjef J. de Kimpe Jan J.G.M. Verschuuren Nathalie Goemans Gert‐Jan B. van Ommen Gerard Platenburg Johan T. den Dunnen
Topics: Muscle Physiology and Disorders (13 papers)Cardiomyopathy and Myosin Studies (4 papers)Viral Infections and Immunology Research (3 papers)
Cited by: Genetics Molecular Biology Cardiology and Cardiovascular Medicine
Journals: New England Journal of Medicine PLoS ONE Scientific Reports
Partner nations: Netherlands Sweden United Kingdom

In The Last Decade

Judith C. van Deutekom

15 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Local Dystrophin Restoration with Antisense Oligonucleotide PRO051

2007 577 citations Judith C. van Deutekom, Anneke A. M. Janson et al. New England Journal of Medicine profile →
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy

2011 518 citations Nathalie Goemans, M. Tulinius et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Judith C. van Deutekom

Since Specialization

Citations

This map shows the geographic impact of Judith C. van Deutekom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith C. van Deutekom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith C. van Deutekom more than expected).

Fields of papers citing papers by Judith C. van Deutekom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith C. van Deutekom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith C. van Deutekom. The network helps show where Judith C. van Deutekom may publish in the future.

Co-authorship network of co-authors of Judith C. van Deutekom

This figure shows the co-authorship network connecting the top 25 collaborators of Judith C. van Deutekom. A scholar is included among the top collaborators of Judith C. van Deutekom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith C. van Deutekom. Judith C. van Deutekom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Low dystrophin variability between muscles and stable expression over time in Becker muscular dystrophy using capillary Western immunoassay 2021 ·Scientific Reports ·Zaïda Koeks,Annika Janson,Chantal Beekman,(unknown),Hermine A. van Duyvenvoorde,J.C. van den Bergen,Melissa T. Hooijmans,(unknown),Ingrid M. Hegeman,Jan J.G.M. Verschuuren,Judith C. van Deutekom,Pietro Spitali,Nicole A. Datson,E. Niks	13
2	Using a State-of-the-Art Toolbox to Evaluate Molecular and Functional Readouts of Antisense Oligonucleotide-Induced Exon Skipping in mdx Mice 2019 ·Nucleic Acid Therapeutics ·Nicole A. Datson,(unknown),Anneke A. M. Janson,(unknown),(unknown),(unknown),Jukka Puoliväli,Kimmo Lehtimäki,Timo Bragge,Toni Ahtoniemi,Judith C. van Deutekom	6
3	Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy 2018 ·PLoS ONE ·Chantal Beekman,Anneke A. M. Janson,(unknown),Judith C. van Deutekom,Nicole A. Datson	86
4	Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study 2016 ·PLoS ONE ·Nathalie Goemans,M. Tulinius,M. van den Hauwe,Anna‐Karin Kroksmark,Gunnar Buyse,Rosamund Wilson,Judith C. van Deutekom,Sjef J. de Kimpe,Afrodite Lourbakos,(unknown)	66
5	A Sensitive, Reproducible and Objective Immunofluorescence Analysis Method of Dystrophin in Individual Fibers in Samples from Patients with Duchenne Muscular Dystrophy 2014 ·PLoS ONE ·Chantal Beekman,Jessica A. Sipkens,(unknown),Stavros Giannakopoulos,(unknown),Judith C. van Deutekom,G. Campion,Sjef J. de Kimpe,Afrodite Lourbakos	33
6	Dystrophin levels and clinical severity in Becker muscular dystrophy patients 2013 ·Journal of Neurology Neurosurgery & Psychiatry ·J.C. van den Bergen,Beatrijs Wokke,Annika Janson,Sjoerd G. van Duinen,Margriet Hulsker,H.B. Ginjaar,Judith C. van Deutekom,Annemieke Aartsma‐Rus,Hermien E. Kan,Jan J.G.M. Verschuuren	94
7	Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy 2013 ·Molecular Therapy — Nucleic Acids ·(unknown),Susan Mulders,(unknown),(unknown),(unknown),(unknown),(unknown),Judith C. van Deutekom,Jack Fransen,Bé Wieringa,Derick G. Wansink	36
8	Antisense oligonucleotides as personalized medicine for Duchenne muscular dystrophy 2013 ·Drug Discovery Today Therapeutic Strategies ·Judith C. van Deutekom,Sjef J. de Kimpe,G. Campion	6
9	Exon skipping for DMD 2012 ·Orphanet Journal of Rare Diseases ·Annemieke Aartsma‐Rus,Jan J.G.M. Verschuuren,G. Campion,Gert‐Jan B. van Ommen,Judith C. van Deutekom	2
10	Systemic Administration of PRO051 in Duchenne's Muscular Dystrophybreakdown → 2011 ·New England Journal of Medicine ·Nathalie Goemans,M. Tulinius,(unknown),(unknown),(unknown),(unknown),Tjadine M. Holling,Anneke A. M. Janson,Gerard Platenburg,Jessica A. Sipkens,J. M. A. Sitsen,Annemieke Aartsma‐Rus,Gert‐Jan B. van Ommen,Gunnar Buyse,Niklas Darín,Jan J.G.M. Verschuuren,G. Campion,Sjef J. de Kimpe,Judith C. van Deutekom	518
11	Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model 2010 ·Molecular Therapy ·Hans Heemskerk,(unknown),(unknown),(unknown),Patrizia Sabatelli,Paola Rimessi,Paola Braghetta,Gert‐Jan B. van Ommen,S. de Kimpe,Alessandra Ferlini,Annemieke Aartsma‐Rus,Judith C. van Deutekom	114
12	Local Dystrophin Restoration with Antisense Oligonucleotide PRO051breakdown → 2007 ·New England Journal of Medicine ·Judith C. van Deutekom,Anneke A. M. Janson,Ieke B. Ginjaar,(unknown),Annemieke Aartsma‐Rus,(unknown),Johan T. den Dunnen,Klaas Koop,Anneke J. van der Kooi,Nathalie Goemans,Sjef J. de Kimpe,(unknown),(unknown),Gerard Platenburg,Jan J.G.M. Verschuuren,Gert‐Jan B. van Ommen	577
13	Comparative Analysis of Antisense Oligonucleotide Sequences for Targeted Skipping of Exon 51 During Dystrophin Pre-mRNA Splicing in Human Muscle 2007 ·Human Gene Therapy ·Virginia Arechavala‐Gomeza,Ian R. Graham,Linda Popplewell,A.M. Adams,Annemieke Aartsma‐Rus,Maria Kinali,Jennifer E. Morgan,Judith C. van Deutekom,Steve D. Wilton,George Dickson,Francesco Muntoni	123
14	Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family 2000 ·European Journal of Human Genetics ·Ieke B. Ginjaar,Alexander L.J. Kneppers,(unknown),Louise V.B. Anderson,(unknown),Judith C. van Deutekom,(unknown),Johan T. den Dunnen,Egbert Bakker	73
15	Mutation in DHP receptor alpha 1 subunit (CACLN1A3) gene in a Dutch family with hypokalaemic periodic paralysis. 1995 ·Journal of Medical Genetics ·R.H. Boerman,(unknown),Thera P. Links,Ronald van Eijk,Lodewijk A. Sandkuijl,Alexis Elbaz,(unknown),Axel R. Wintzen,Judith C. van Deutekom,(unknown)	23

About Judith C. van Deutekom

Judith C. van Deutekom is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and Physiology, having authored 15 papers that have together received 1.8k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (13 papers), Cardiomyopathy and Myosin Studies (4 papers) and Viral Infections and Immunology Research (3 papers). The work is most often cited by research in Genetics (393 citations), Molecular Biology (1.7k citations) and Cardiology and Cardiovascular Medicine (335 citations). Judith C. van Deutekom has collaborated with scholars based in Netherlands, Sweden and United Kingdom. Frequent co-authors include Annemieke Aartsma‐Rus, Anneke A. M. Janson, Sjef J. de Kimpe, Jan J.G.M. Verschuuren, Nathalie Goemans, Gert‐Jan B. van Ommen, Gerard Platenburg, Johan T. den Dunnen, Ieke B. Ginjaar and Klaas Koop. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact